4//SEC Filing
Basso Stephen 4
Accession 0001209191-21-021482
CIK 0001693011other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 5:56 PM ET
Size
5.5 KB
Accession
0001209191-21-021482
Insider Transaction Report
Form 4
Basso Stephen
Senior Vice President, Finance
Transactions
- Award
Stock Option (right to buy)
2021-03-04+27,000→ 27,000 totalExercise: $19.78Exp: 2031-03-03→ Common Stock (27,000 underlying)
Footnotes (1)
- [F1]The option was granted on March 4, 2021. The shares underlying the option are scheduled to vest in equal monthly installments from March 4, 2021 through March 4, 2025.
Documents
Issuer
Inozyme Pharma, Inc.
CIK 0001693011
Entity typeother
Related Parties
1- filerCIK 0001815707
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 5:56 PM ET
- Size
- 5.5 KB